NCT00904085View on ClinicalTrials.gov

Post-operative Efficacy and Safety Study

PHASE3CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

June 30, 2003

Study Completion Date

June 30, 2003

Conditions
Post-operative Pain
Interventions
DRUG

Oxymorphone IR

5 mg

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY